GT BIOPHARMA INC's ticker is GTBP and the CUSIP is 36254L209. A total of 57 filers reported holding GT BIOPHARMA INC in Q4 2021. The put-call ratio across all filers is 2.63 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $0 | – | 454 | +13.5% | 0.00% | – |
Q2 2023 | $0 | – | 400 | +44.9% | 0.00% | – |
Q4 2022 | $0 | -100.0% | 276 | -72.3% | 0.00% | – |
Q3 2022 | $1,000 | -80.0% | 998 | -47.7% | 0.00% | – |
Q2 2022 | $5,000 | -68.8% | 1,909 | -66.5% | 0.00% | – |
Q1 2022 | $16,000 | -15.8% | 5,692 | -9.8% | 0.00% | – |
Q4 2021 | $19,000 | +1800.0% | 6,310 | +9317.9% | 0.00% | – |
Q3 2021 | $1,000 | 0.0% | 67 | 0.0% | 0.00% | – |
Q2 2021 | $1,000 | – | 67 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Baskin Financial Services Inc. | 151,354 | $36 | 0.00% |
Moss Adams Wealth Advisors LLC | 20,000 | $4,822 | 0.00% |
UBS Group AG | 8,750 | $2,109 | 0.00% |
Compagnie Lombard Odier SCmA | 50,000 | $12,055 | 0.00% |
OSAIC HOLDINGS, INC. | 1,270 | $305 | 0.00% |
FMR LLC | 150 | $36 | 0.00% |
BANK OF AMERICA CORP /DE/ | 508 | $122 | 0.00% |
WELLS FARGO & COMPANY/MN | 300,697 | $72,498 | 0.00% |
NORTHERN TRUST CORP | 32,347 | $7,799 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |